"In silico studies of natural product-like caffeine derivatives as ..."

Yassir Boulaamane et al. (2022)

> Home

Details and statistics

DOI: 10.1515/JIB-2021-0027

access: open

type: Journal Article

metadata version: 2023-01-31

- view
  - electronic edition via DOI (open access)
  authority control:
- export record
  dblp key:
  - journals/jib/BoulaamaneIBM22
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jib/BoulaamaneIBM22
Yassir Boulaamane, Mahmoud A. A. Ibrahim, Mohammed-Reda Britel, Amal A. M. Maurady:
In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AA_2AR antagonists for the treatment of Parkinson's disease. J. Integr. Bioinform. 19(4) (2022)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.